Sexual Dysfunction
📧 Sign up to get email alerts when something new happens for Sexual Dysfunction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2022-12-21Clinical Trial Update: Natesto Testosterone Nasal Gel for Hypogonadal Men [Phase 4]
Phase 4 trial of Natesto testosterone nasal gel for hypogonadal men has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-04Clinical Trial Update: A Survey of Sexual Function in Schizophrenic Patients
This clinical trial update notes that a study assessing sexual function in schizophrenia patients was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-10-18Clinical Trial Update: Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas
The clinical trial investigating sexual function in Crohn's disease patients with perianal fistulas has been withdrawn.
-
EMA withdrawal · 2012-06-18EMA Withdrawn: Intrinsa (testosterone) — Warner Chilcott UK Ltd.
EMA withdrew Intrinsa, a testosterone product for sexual dysfunction, from the market in 2012.
-
EMA withdrawal · 2012-04-16EMA Withdrawn: Livensa (testosterone) — Warner Chilcott Deutschland GmbH
Withdrawn medicine Livensa (testosterone) by Warner Chilcott Deutschland GmbH; status indicates full withdrawal from market.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.